Thomas Tan
Private Equity Investor bij Lundbeckfonden Ventures
Actieve functies van Thomas Tan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Lundbeckfonden Ventures
Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures (Lundbeckfonden Ventures) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2009 and is headquartered in Copenhagen, Denmark. | Private Equity Investor | 01-01-2021 | - |
Sound Bioventures Management ApS | Private Equity Investor | 01-04-2022 | - |
Sound Bioventures Management AB
Sound Bioventures Management AB Investment ManagersFinance Sound Bioventures Management AB is a venture capital firm founded in 2021 by Casper Breum, Johan Kordel and Bibhash Mukhopadhyay. The firm is headquartered in Malmo, Sweden. | Private Equity Investor | 01-01-2022 | - |
Loopbaan van Thomas Tan
Eerdere bekende functies van Thomas Tan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Varmx BV
Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Directeur/Bestuurslid | 01-10-2021 | 30-04-2022 |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Directeur/Bestuurslid | 01-10-2021 | 30-04-2022 |
Lifescience Dynamics Ltd. | Corporate Officer/Principal | 01-07-2020 | 31-01-2021 |
Huron Consulting Services U.K. Ltd.
Huron Consulting Services U.K. Ltd. Miscellaneous Commercial ServicesCommercial Services Pope Woodhead & Associates Ltd. provides management consultancy services. The company was founded on November 9, 2006 and is headquartered in Saint Ivens, the United Kingdom. | Corporate Officer/Principal | 01-01-2019 | 31-07-2020 |
Opleiding van Thomas Tan
University of Oxford | Doctorate Degree |
University of Copenhagen | Graduate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 4 |
Denemarken | 4 |
Israël | 2 |
Operationeel
Private Equity Investor | 3 |
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Sectoraal
Finance | 4 |
Consumer Services | 3 |
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 7 |
---|---|
Lundbeckfonden Ventures
Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures (Lundbeckfonden Ventures) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2009 and is headquartered in Copenhagen, Denmark. | Finance |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Health Technology |
Varmx BV
Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Health Technology |
Huron Consulting Services U.K. Ltd.
Huron Consulting Services U.K. Ltd. Miscellaneous Commercial ServicesCommercial Services Pope Woodhead & Associates Ltd. provides management consultancy services. The company was founded on November 9, 2006 and is headquartered in Saint Ivens, the United Kingdom. | Commercial Services |
Lifescience Dynamics Ltd. | |
Sound Bioventures Management AB
Sound Bioventures Management AB Investment ManagersFinance Sound Bioventures Management AB is a venture capital firm founded in 2021 by Casper Breum, Johan Kordel and Bibhash Mukhopadhyay. The firm is headquartered in Malmo, Sweden. | Finance |
Sound Bioventures Management ApS | Finance |
- Beurs
- Insiders
- Thomas Tan
- Ervaring